Leukemia-cell rejection due to T-region encoded antigens. 1981

G Biasi, and D Collavo, and P Zanovello, and L Chieco-Bianchi

The role of H-2- and T-region products in determining allogeneic cell rejection was evaluated in H-2 congenic and recombinant mice by transplanting A1ATH and A6ATL leukemia cell lines induced in A.TH and A.TL strains, respectively, by Moloney murine leukemia virus.--In K- or D-region incompatible hosts transplant failure was observed, while in I + T-region incompatible hosts either rejection or prolonged survival was seen. In mice preimmunized with spleen cells from I- and/or T-region incompatible donors, leukemia cells were rejected by mice immune only to T-region products, and accepted by mice immune only to I-region products.--Cell-mediated cytotoxicity studies confirmed in vivo results. Secondary CTLs specifically directed against I-region products did not lyse the A1ATH and A6ATL cells, and secondary CTLs from A.TH and A.TL mice sensitized against A6ATL and A1ATH cells respectively exerted a lytic action specific for T-region products, while no activity was observed against I determinants.--The data suggest that tumor-transplant rejection may also be governed by histocompatibility antigens encoded in the T region.

UI MeSH Term Description Entries
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D008297 Male Males
D008805 Mice, Inbred A An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. Mouse, Inbred A,Inbred A Mice,Inbred A Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D005260 Female Females
D005815 Genetic Code The meaning ascribed to the BASE SEQUENCE with respect to how it is translated into AMINO ACID SEQUENCE. The start, stop, and order of amino acids of a protein is specified by consecutive triplets of nucleotides called codons (CODON). Code, Genetic,Codes, Genetic,Genetic Codes
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft

Related Publications

G Biasi, and D Collavo, and P Zanovello, and L Chieco-Bianchi
October 1984, Science (New York, N.Y.),
G Biasi, and D Collavo, and P Zanovello, and L Chieco-Bianchi
February 1989, Immunological reviews,
G Biasi, and D Collavo, and P Zanovello, and L Chieco-Bianchi
January 1979, Haematology and blood transfusion,
G Biasi, and D Collavo, and P Zanovello, and L Chieco-Bianchi
January 1983, Annals of the New York Academy of Sciences,
G Biasi, and D Collavo, and P Zanovello, and L Chieco-Bianchi
November 2019, Internal medicine (Tokyo, Japan),
G Biasi, and D Collavo, and P Zanovello, and L Chieco-Bianchi
January 1984, Princess Takamatsu symposia,
G Biasi, and D Collavo, and P Zanovello, and L Chieco-Bianchi
March 1989, The EMBO journal,
G Biasi, and D Collavo, and P Zanovello, and L Chieco-Bianchi
March 1998, Nature medicine,
G Biasi, and D Collavo, and P Zanovello, and L Chieco-Bianchi
September 1992, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!